{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:16:30Z","timestamp":1792635390494,"version":"4.5.0"},"reference-count":49,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Ophthalmology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.3109\/08820538.2010.541318","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T10:41:31Z","timestamp":1306233691000},"page":"104-113","source":"Crossref","is-referenced-by-count":48,"title":["Intravitreal Injection Technique"],"prefix":"10.3109","volume":"26","author":[{"given":"Rishi R.","family":"Doshi","sequence":"first","affiliation":[{"name":"California Pacific Medical Center, Department of Ophthalmology, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie J.","family":"Bakri","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Ophthalmology, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Fung","sequence":"additional","affiliation":[{"name":"Pacific Eye Associates, California Pacific Medical Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,5,24]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01977971"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1947.00890220314006"},{"key":"e_1_3_2_4_1","unstructured":"FDA website: http:\/\/www.accessdata.fda.gov\/Scripts\/cder\/DrugsatFDA\/"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.099598"},{"issue":"9","key":"e_1_3_2_6_1","article-title":"Score Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5","volume":"127","author":"Ip MS","year":"2009","unstructured":"Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH. Score Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127(9):1101-14.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"e_1_3_2_7_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion six-month primary end point results of a phase III study","volume":"117","author":"Brown DM","year":"2010","unstructured":"Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion six-month primary end point results of a phase III study. Ophthalmology 2010;117(6):1124-33.","journal-title":"Ophthalmology"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042760"},{"issue":"5","key":"e_1_3_2_9_1","doi-asserted-by":"crossref","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: Acomprehensive review","volume":"24","author":"Jager RD","year":"2004","unstructured":"Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: Acomprehensive review. Retina 2004;24(5):676-98.","journal-title":"Retina"},{"issue":"13","key":"e_1_3_2_10_1","doi-asserted-by":"crossref","DOI":"10.1517\/14656560903081752","article-title":"Endophthalmitis after intravitreal injections","volume":"10","author":"Schwartz SG","year":"2009","unstructured":"Schwartz SG, Flynn HW, Scott IU. Endophthalmitis after intravitreal injections. Expert Opin Pharmacother 2009;10(13):2119-26.","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"e_1_3_2_11_1","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e3181884fd2","article-title":"Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab","volume":"28","author":"Fintak DR","year":"2008","unstructured":"Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 2008;28(10):1395-9.","journal-title":"Retina"},{"issue":"12","key":"e_1_3_2_12_1","article-title":"Safety monitoring with ocular anti-vascular endothelial growth factor therapies","volume":"92","author":"Fung AE","year":"2008","unstructured":"Fung AE, Bhisitkul RB. Safety monitoring with ocular anti-vascular endothelial growth factor therapies. Br J Ophthalmol 2008;92(12):1573-4.","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200410001-00002"},{"issue":"4","key":"e_1_3_2_14_1","doi-asserted-by":"crossref","DOI":"10.1038\/sj.eye.6702232","article-title":"National survey of the technique of intravitreal triamcinolone injection in the United Kingdom","volume":"21","author":"Anijeet DR","year":"2007","unstructured":"Anijeet DR, Hanson RJ, Bhagey J, Bates RA. National survey of the technique of intravitreal triamcinolone injection in the United Kingdom. Eye (Lond) 2007;21(4):480-6.","journal-title":"Eye (Lond)"},{"issue":"7","key":"e_1_3_2_15_1","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e318154b9f2","article-title":"Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections","volume":"27","author":"Charles S","year":"2007","unstructured":"Charles S, Rosenfeld PJ, Gayer S. Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections. Retina 2007;27(7):813-5.","journal-title":"Retina"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.7.994"},{"issue":"9","key":"e_1_3_2_17_1","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.1985.01050090092039","article-title":"Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic","volume":"103","author":"Isenberg SJ","year":"1985","unstructured":"Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol 1985;103(9):1340-2.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"e_1_3_2_18_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2005.01.025","article-title":"Acute-onset endophthalmitis after cataract surgery (2000\u20132004): incidence, clinical settings, and visual acuity outcomes after treatment","volume":"139","author":"Miller JJ","year":"2005","unstructured":"Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000\u20132004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005;139(6):983\u2013987.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"e_1_3_2_19_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1442-9071.2006.01231.x","article-title":"Intravitreous injections","volume":"34","author":"Bylsma G","year":"2006","unstructured":"Bylsma G, Guymer R, Qureshi S, Gin T, Allen P, Madhok P, McCombe M, Harper A. Intravitreous injections. Clin Experiment Ophthalmol 2006;34(4):388-90.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"e_1_3_2_20_1","article-title":"[Intravitreal injections of medications in Germany. Contract situation and legal conditions]","volume":"106","author":"Ziemssen F","year":"2009","unstructured":"Ziemssen F, Wiedemann P, Kampik A, Holz F, Bartz-Schmidt KU. [Intravitreal injections of medications in Germany. Contract situation and legal conditions]. Ophthalmologe 2009;106(5):465-70.","journal-title":"Ophthalmologe"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2007.00979.x"},{"issue":"1","key":"e_1_3_2_22_1","doi-asserted-by":"crossref","DOI":"10.1038\/sj.eye.6702938","article-title":"Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab","volume":"23","author":"Bakri SJ","year":"2009","unstructured":"Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond) 2009;23(1):181-5.","journal-title":"Eye (Lond)"},{"issue":"1","key":"e_1_3_2_23_1","doi-asserted-by":"crossref","DOI":"10.3928\/15428877-20090101-05","article-title":"Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab","volume":"40","author":"Cintra LP","year":"2009","unstructured":"Cintra LP, Lucena LR, Da Silva JA, Costa RA, Scott IU, Jorge R. Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40(1):13-8.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_3_2_24_1","unstructured":"Intravitreal Injection Survey. Anti-infection procedures are still evolving. Retin Physician 2006. www.retinalphysician.com\/article.aspx?article=&loc=archive\\2006\\may\\0506055.htm. Accessed December 8 2009."},{"issue":"8","key":"e_1_3_2_25_1","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e3181aade74","article-title":"Tunnelled versus straight intravitreal injection: Intraocular pressure changes, vitreous reflux, and patient discomfort","volume":"29","author":"Knecht PB","year":"2009","unstructured":"Knecht PB, Michels S, Sturm V, Bosch MM, Menke MM. Tunnelled versus straight intravitreal injection: Intraocular pressure changes, vitreous reflux, and patient discomfort. Retina 2009;29(8):1175-81.","journal-title":"Retina"},{"issue":"4","key":"e_1_3_2_26_1","article-title":"An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration","volume":"143","author":"Fung AE","year":"2007","unstructured":"Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143(4):566-83.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"e_1_3_2_27_1","doi-asserted-by":"crossref","DOI":"10.1097\/00006982-200512000-00007","article-title":"Lidocaine gel anesthesia for intravitreal drug administration","volume":"25","author":"Kozak I","year":"2005","unstructured":"Kozak I, Cheng L, Freeman WR. Lidocaine gel anesthesia for intravitreal drug administration. Retina 2005;25(8):994-8.","journal-title":"Retina"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s4935"},{"issue":"10","key":"e_1_3_2_29_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrs.2008.05.056","article-title":"Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival","volume":"34","author":"Boden JH","year":"2008","unstructured":"Boden JH, Myers ML, Lee T, Bushley DM, Torres MF. Effect of lidocaine gel on povidone-iodine antisepsis and microbial survival. J Cataract Refract Surg 2008;34(10):1773\u20131775.","journal-title":"J Cataract Refract Surg"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.1997.11.1.51"},{"issue":"5","key":"e_1_3_2_31_1","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.37.5.1564-1566.1999","article-title":"Abiotrophia species as a cause of endophthalmitis following cataract extraction","volume":"37","author":"Namdari H","year":"1999","unstructured":"Namdari H, Kintner K, Jackson BA, Namdari S, Hughes JL, Peairs RR, Savage DJ. Abiotrophia species as a cause of endophthalmitis following cataract extraction. J Clin Microbiol 1999;37(5):1564-6.","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32052-9"},{"issue":"1","key":"e_1_3_2_33_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.0105-1873.2005.00479.x","article-title":"Allergic contact dermatitis from povidone-iodine: A re-evaluation study","volume":"52","author":"Lachapelle JM","year":"2005","unstructured":"Lachapelle JM. Allergic contact dermatitis from povidone-iodine: A re-evaluation study. Contact Dermatitis 2005;52(1):9-10.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"e_1_3_2_34_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0420.2005.00414.x","article-title":"Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting","volume":"83","author":"Barkana Y","year":"2005","unstructured":"Barkana Y, Almer Z, Segal O, Lazarovitch Z, Avni I, Zadok D. Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand 2005;83(3):360-3.","journal-title":"Acta Ophthalmol Scand"},{"key":"e_1_3_2_35_1","first-page":"434","article-title":"Povidone-iodine as an ophthalmic antiseptic","volume":"17","author":"Kiffney GT","year":"1966","unstructured":"Kiffney GT, Hattaway AC. Povidone-iodine as an ophthalmic antiseptic. Surg Forum 1966;17:434\u2013435.","journal-title":"Surg Forum"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.2.163"},{"issue":"5","key":"e_1_3_2_37_1","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-007-9073-6","article-title":"The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections","volume":"27","author":"Safar A","year":"2007","unstructured":"Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol 2007;27(5):307-12.","journal-title":"Int Ophthalmol"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702577"},{"issue":"7","key":"e_1_3_2_39_1","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e31816c6868","article-title":"Intravitreal silicone oil droplets after intravitreal drug injections","volume":"28","author":"Bakri SJ","year":"2008","unstructured":"Bakri SJ, Ekdawi NS. Intravitreal silicone oil droplets after intravitreal drug injections. Retina 2008;28(7):9961\u2013001.","journal-title":"Retina"},{"issue":"5","key":"e_1_3_2_40_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.06.004","article-title":"SCORE Study Investigator Group. SCORE Study Report 7: Incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design","volume":"148","author":"Scott IU","year":"2009","unstructured":"Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN. SCORE Study Investigator Group. SCORE Study Report 7: Incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. Am J Ophthalmol 2009;148(5):725\u2013732.e7.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"e_1_3_2_41_1","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e3181a94f01","article-title":"Intravitreal injection of therapeutic agents","volume":"29","author":"Peyman GA","year":"2009","unstructured":"Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina 2009;29(7):875\u2013912.","journal-title":"Retina"},{"key":"e_1_3_2_42_1","article-title":"Steps for a Safe Intravitreal Injection Technique: A look at how European and American approaches compare","author":"Carsten HM","year":"2009","unstructured":"Carsten HM, Fung AE, Saxena S, Frank GH. Steps for a Safe Intravitreal Injection Technique: A look at how European and American approaches compare. Retinal Physician 2009 Jul.","journal-title":"Retinal Physician"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.16.7.663.5061"},{"issue":"6","key":"e_1_3_2_44_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2007.01.035","article-title":"Tunneled scleral incision to prevent vitreal reflux after intravitreal injection","volume":"143","author":"Rodrigues EB","year":"2007","unstructured":"Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol 2007;143(6):1035-7.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"e_1_3_2_45_1","article-title":"Vitreous wick syndrome\u2014A potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana","volume":"137","author":"Chen SD","year":"2004","unstructured":"Chen SD, Mohammed Q, Bowling B, Patel CK. Vitreous wick syndrome\u2014A potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am J Ophthalmol 2004;137(6):1159-60.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"e_1_3_2_46_1","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e3181b094cf","article-title":"Experimental model of intravitreal injection techniques","volume":"30","author":"Hubschman JP","year":"2010","unstructured":"Hubschman JP, Coffee RE, Bourges JL, Yu F, Schwartz SD. Experimental model of intravitreal injection techniques. Retina 2010;30(1):167-73.","journal-title":"Retina"},{"issue":"1","key":"e_1_3_2_47_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.02.013","article-title":"Bilateral simultaneous intravitreal injections in the office setting","volume":"148","author":"Bakri SJ","year":"2009","unstructured":"Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 2009;148(1):66-9.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4835(03)00214-8"},{"issue":"6","key":"e_1_3_2_49_1","article-title":"Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents","volume":"146","author":"Kim JE","year":"2008","unstructured":"Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146(6):930-4.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"e_1_3_2_50_1","doi-asserted-by":"crossref","DOI":"10.1097\/WNO.0b013e3181a58fd1","article-title":"Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab","volume":"29","author":"Hosseini H","year":"2009","unstructured":"Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol 2009;29(2):160-1.","journal-title":"J Neuroophthalmol"}],"container-title":["Seminars in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08820538.2010.541318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:16:33Z","timestamp":1753100193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08820538.2010.541318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.3109\/08820538.2010.541318"],"URL":"https:\/\/doi.org\/10.3109\/08820538.2010.541318","relation":{},"ISSN":["0882-0538","1744-5205"],"issn-type":[{"value":"0882-0538","type":"print"},{"value":"1744-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}